Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment and Prepayment of Debt
Prepayment or repayment of existing borrowings incurred by the company and its subsidiaries.
Purchase of Medical Equipment
Procurement of advanced medical devices and diagnostic machinery for existing and expanding hospital facilities.
General Corporate Purposes
Meeting corporate expansion needs, working capital requirements, and issue-related expenses.
No documents added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Aster DM Healthcare Limited is an integrated healthcare service provider operating across India and GCC (Gulf Cooperation Council) countries. Founded by Dr. Azad Moopen, the organization has grown into a major hospital network offering primary, secondary, tertiary, and quaternary healthcare services. Its portfolio encompasses multispecialty hospitals, outpatient clinics, diagnostic centers, and retail pharmacies, catering to a diverse patient demographic across multiple geographies. The company's operations are structured around providing high-quality medical care backed by advanced clinical technology and specialized departments. Across its hospital network, Aster operates well-established brands including Aster Medcity, Aster CMI Hospital, and Aster MIMS. Its clinical capabilities cover key specialties such as cardiology, oncology, neurosciences, gastroenterology, and organ transplant services, supported by a large clinical workforce of doctors, nurses, and medical professionals. With a strategic focus on expanding its bed capacity and enhancing operational efficiencies, Aster DM Healthcare continues to strengthen its presence in both domestic and international markets. The company leverages clinical governance protocols, modern medical equipment, and digital health initiatives to drive patient engagement, expand access to care, and maintain growth across its healthcare verticals.
Aster DM Healthcare raised ₹294.04 crore from institutional anchor investors by allocating 1,54,75,843 equity shares at ₹190 per share.
Source: RHP • Analysis provided for informational purposes
Last Updated: 30 July 2026, 4:06 PM
Established Healthcare Brand and Geographical Presence
Operating a well-recognized hospital network across India and GCC countries with multiple tertiary and quaternary care facilities.
Diversified Revenue Stream and Clinical Capabilities
Offers comprehensive healthcare services including multi-specialty hospitals, clinics, and pharmacies with strong patient trust.
Experienced Management and Medical Teams
Led by experienced healthcare professionals and supported by highly skilled doctors and administrative teams.
Regulatory Risk and Price Controls
Subject to government regulations regarding healthcare pricing, medical equipment costs, and operational compliance.
Capital Intensive Business and Leverage
Requires substantial ongoing capital expenditure for medical equipment and expansion, with existing debt obligations.
Aster DM Health Care Limited
No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Ameerpet, Hyderabad - 500038, Telangana, India
View on Maps →MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.